Genmab — December 2018
-
-
-
Mateos : DaraVMP is a new standard of care for NDMM not eligible for transplant that can be potentially affordable in many countries due to the fact that bortezomib, melphalan and prednisone is not an expensive combination so dara would be the only new and more expensive agent https://medicalresearch.com/cancer-_-oncology/alcyone-trial-daravmp-new-standard-for-transplant-ineligible-newly-diagnosed-multiple-myeloma/46284/
-
Isatuximab + VRD https://twitter.com/NorthTxMSG/status/1069609328015884288
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind